Zhuzhou Yuancheng Hezhong Technology Development Co., Ltd.

You are here: HomeProductsToremifene Citrate

Contact us

  • Company Name: Zhuzhou Yuancheng Hezhong Technology Development Co., Ltd.
  • Country/region: China
  • Contact Person: Mr.Jay Cai
  • Tel: 86-731-22290202
  • Email:

Toremifene Citrate

  • CAS No:89778-27-8 2-[4-[(Z)-4-chloro-1,2-diphenylbut-1-enyl]phenoxy]-N,<br />N-dimethylethanamine
    Molecular Structure

    Detailed Description

    Toremifene Citrate
    Synonyms: FC 1157a; Fareston; NK 622; NSC 613680
    CAS: 89778-27-8
    Melting Point: 158-164 oC
    Boiling Point: 535.1 oC at 760 mmHg
    Density: 1.045g/cm3
    Molecular Formula: C26H28ClNO·C6H8O7
    Molecular Weight: 598.09
    Appearance: White or almost white powder
    Packing: foil bag
    Payment: Bank Transfer, Western Union, Money Gram
    Express: EMS, DHL, FedEx, etc(door-to-door)
    Delivery: Safe & timely, around 1-3 days after payment

    Description:
    It is a member of a category, family, and class of drugs that are known as SERMs (Selective Estrogen Receptor Modulators). SERMs fall under an even broader category of drugs that are known as anti-estrogens, and the cousin family of SERMs (that also fall under anti-estrogens) are aromatase inhibitors, commonly abbreviated as AIs. SERMs include compounds such as Nolvadex and Clomid (Clomiphene Citrate). Aromatase inhibitors (AIs) include compounds such as Arimidex ) Aromasin, (Femara). Although the two fall under the category of anti-estrogens, they are both sub-categories that branch off into their own families, as SERMs and AIs differ greatly in their mechanism of action within the human body concerning how they control or block Estrogen. There has been much misunderstanding and misconception in previous decades as to what each of these do, and this should always be first clarified to the reader before describing Toremifene.

    Applications:
    Toremifene citrate is an oral selective estrogen receptor modulator (SERM) which helps oppose the actions of estrogen in the body. Licensed in the United States under the brand name Fareston, toremifene citrate is FDA-approved for use in advanced (metastatic) breast cancer. It is also being evaluated for prevention of prostate cancer under the brand name Acapodene.
    It has already been covered that Toremifene is a SERM, and serves to block Estrogen at various receptor sites in certain tissues within the body (breast tissue in particular). As a layman explanation, Toremifene pretends to be a 'fake' Estrogen that occupies Estrogen receptors within breast tissue. With these receptors occupied by Toremifene, real Estrogen cannot perform their jobs there.
    Toremifene does not reduce total blood plasma levels of Estrogen. In addition to being antagonistic to Estrogen receptors in breast tissue, it is also antagonistic to Estrogen at the hypothalamus gland (this essentially 'tricks' the hypothalamus into thinking there is little or no circulating Estrogen levels in the body, causing it to increase its manufacture of Testosterone so that it can utilize aromatization to restore these levels.
    Toremifene is also agonistic to Estrogen receptors in other tissues in the body (within the liver in particular). This means that whileToremifene will act as an anti-estrogen in breast tissue and the hypothalamus, it will act as an Estrogen within the liver. This can have beneficial impacts especially during an anabolic steroid cycle, such as improving and shifting cholesterol levels into a more favorable range.

    ycgl01@yccreate.com
    skype: echo01_5
    Tel:18188938036
    http://www.sellsteroids.com
  • Toremifene Citrate
  • Toremifene Citrate